Evidence map›Paper›PMID 33644482›Full record

ArticleHeliyon2021

Presymptomatic viral shedding and infective ability of SARS-CoV-2; a case report.

Karolina Nissen, Marie Hagbom, Janina Krambrich, Dario Akaberi, Sumit Sharma, Jiaxin Ling, Tove Hoffman, Lennart Svensson, Kåre Bondeson, Erik Salaneck

Erratum issuedAbstract readCase Reports
In one paragraph

Article in Heliyon, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Karolina NissenDept of Medical Sciences, Uppsala University, Uppsala, Sweden.
Marie HagbomDept of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Janina KrambrichDept of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Dario AkaberiDept of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Sumit SharmaDept of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Jiaxin LingDept of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Tove HoffmanDept of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Lennart SvenssonDept of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Kåre BondesonDept of Medical Sciences, Uppsala University, Uppsala, Sweden.
Erik SalaneckDept of Medical Sciences, Uppsala University, Uppsala, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Possible pre- or asymptomatic transmission has been reported, both from SARS-CoV and from MERS-CoV outbreaks, although this appears to be uncommon. In contrast, during the COVID-19 pandemic, an increasing number of studies and case reports indicate that pre- or asymptomatic transmission of SARS-CoV-2 is not only possible but also occurs frequently. We report repeated rRT-PCR detection of SARS-CoV-2 in a health care worker and demonstrate infective ability up to three days prior to mild COVID-19 symptoms. rRT-PCR indicated high viral levels approximately three days after exposure. Viral samples collected one and three days prior to symptoms exhibited infectivity on Vero E6 cells, confirmed by detection of double-stranded RNA by immunofluorescence, assessment of cytopathic effect (CPE) and rRT-PCR. SARS-CoV-2 specific IgM and IgG antibodies were detected by day 9 and 15, respectively, after symptom onset. We propose that this provides evidence for potential early presymptomatic transmission of SARS-CoV-2 and that infectivity may be manifest shortly after exposure.

Indexed as

AntibodyCell cultureCoronavirusCOVID-19EpidemiologyHealth care workersInfectivityPresymptomatic transmissionSARS-CoV-2

Identifiers

PMID33644482
PMCPMC7894094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.